Neumora Therapeutics (NMRA) Stock Chart & Stock Price History $0.67 -0.05 (-6.66%) As of 01:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neumora Therapeutics Stock Price Performance The Neumora Therapeutics (NMRA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 92.74%, with a year-to-date return of -93.62%. In the past month, the stock has decreased 4.91%, reflecting recent market activity. As of the latest close, Neumora Therapeutics traded at $0.72 with a market cap of $116.10 million and volume of 390,024 shares. Receive NMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.43%1 Month Performance-4.91%3 Month Performance-62.44%Year-To-Date Performance-93.62%1 Year Performance-92.74% NMRA Stock Chart for Friday, May, 23, 2025 NMRA Chart by TradingView Neumora Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.75$0.72-4.88%$0.77$0.71390,024 shs$116.10 million05/21/2025$0.73$0.75+3.41%$0.78$0.711.36 million shs$122.06 million05/20/2025$0.69$0.73+5.68%$0.73$0.69596,321 shs$118.03 million05/19/2025$0.70$0.69-1.36%$0.74$0.661.23 million shs$111.69 million05/16/2025$0.67$0.70+5.14%$0.72$0.651.19 million shs$113.22 million05/15/2025$0.62$0.67+8.24%$0.67$0.62974,886 shs$107.69 million05/14/2025$0.68$0.62-9.46%$0.70$0.61995,292 shs$99.49 million05/13/2025$0.69$0.68-1.89%$0.75$0.66972,655 shs$109.89 million05/12/2025$0.66$0.69+4.48%$0.77$0.671.22 million shs$112.01 million05/09/2025$0.63$0.66+4.71%$0.69$0.64755,462 shs$107.21 million Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.65$0.63-2.31%$0.69$0.631.08 million shs$102.39 million05/07/2025$0.67$0.65-3.69%$0.72$0.64675,839 shs$104.81 million05/06/2025$0.70$0.67-3.56%$0.71$0.67561,542 shs$108.82 million05/05/2025$0.78$0.70-10.13%$0.78$0.70802,773 shs$112.84 million05/02/2025$0.77$0.78+0.62%$0.80$0.76878,672 shs$125.55 million05/01/2025$0.78$0.77-1.08%$0.79$0.73738,001 shs$124.77 million04/30/2025$0.77$0.78+1.67%$0.78$0.73804,157 shs$126.13 million04/29/2025$0.76$0.77+0.58%$0.79$0.74651,106 shs$124.06 million04/28/2025$0.76$0.76+0.67%$0.80$0.74793,164 shs$123.35 million04/25/2025$0.75$0.76+1.07%$0.76$0.73909,038 shs$121.23 million04/24/2025$0.71$0.75+5.43%$0.76$0.701.12 million shs$121.23 million04/23/2025$0.71$0.71+0.84%$0.81$0.691.53 million shs$114.99 million04/22/2025$0.66$0.71+6.82%$0.72$0.67787,081 shs$114.03 million Related Companies Maze Therapeutics Stock Chart SIGA Technologies Stock Chart Zevra Therapeutics Stock Chart Sage Therapeutics Stock Chart Amylyx Pharmaceuticals Stock Chart Prothena Stock Chart PureTech Health Stock Chart ABIVAX Société Anonyme Stock Chart Tourmaline Bio Stock Chart Precigen Stock Chart Receive NMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NMRA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
